Akchinec-DS Oral Suspension
Marketer
Azurite Therapeutics Pvt.Ltd.
Salt Composition
Levocetirizine (4mg/5ml) + Montelukast (2.5mg/5ml)
Overview Akchinec-DS Oral Suspension
Allergic symptoms like nasal congestion, sneezing, itching, watery eyes, and swelling respond to Akchinec-DS Oral Suspension, a combination drug. This medication eases airway inflammation, improving breathing. Dosage and duration are determined by your physician and depend on individual response. Continue treatment as directed; premature discontinuation may lead to symptom recurrence and condition exacerbation. Inform your doctor of all other medications you're using, as interactions are possible. Common side effects include nausea, diarrhea, vomiting, dry mouth, headache, rash, flu-like symptoms, and tiredness; most are transient. Report any concerning side effects immediately. Drowsiness and dizziness are possible; avoid driving or tasks requiring concentration until effects are known. Alcohol should be avoided due to increased sleepiness. Self-medication and recommending this drug to others are strongly discouraged. Adequate hydration is advised. Patients with kidney disease must inform their doctor before starting this medication.
Uses of Akchinec-DS Oral Suspension
Managing allergic skin reactions | Alleviating allergic rhinitis symptoms (sneezing and rhinorrhea) | Treating seasonal allergic conjunctivitis and rhinitis
Major Benefits of Akchinec-DS Oral Suspension:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Consult the product label for comprehensive instructions prior to consumption. Use a measuring device for accurate dosing and ingest orally. Ensure thorough shaking before each use. Akchinec-DS Oral Suspension can be consumed with or without food; however, consistent timing is recommended for optimal therapeutic effect.
Common Side effects of Akchinec-DS Oral Suspension:
- Nausea
- Diarrhea
- Dryness in mouth
- Fatigue
- Headache
- Skin rash
- Sleepiness
- Vomiting
- Upper respiratory tract infection
- Sore throat
- Fever
- Abdominal pain
- Increased liver enzymes
How to use Akchinec-DS Oral Suspension:
Administer this medication according to your physician's prescribed dosage and schedule. Always refer to the product label for usage instructions. Use a measuring device for accurate dosing and oral ingestion. Ensure thorough shaking prior to each use. Akchinec-DS Oral Suspension can be consumed with or without food; however, consistent timing is recommended.
How Akchinec-DS Oral Suspension works:
Allergeaze Oral Suspension combines levocetirizine and montelukast to alleviate allergic sneezing and rhinorrhea. Levocetirizine, an antihistamine, counteracts histamine, a chemical mediator causing nasal discharge, lacrimation, and sneezing. Montelukast, a leukotriene receptor antagonist, inhibits leukotriene activity, thus lessening airway and nasal inflammation and improving symptoms.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Akchinec-DS Oral Suspension with alcohol. Seek medical advice before doing so.
PregnancySAFE IF PRESCRIBED
The oral suspension formulation of Akchinec-DS is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no harmful consequences to the fetus; nevertheless, data from human trials are scarce.
Breast feedingUNSAFE
Administering Akchinec-DS Oral Suspension while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Taking Akchinec-DS Oral Suspension might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Refrain from driving if these effects arise.
KidneyCAUTION
Patients with kidney impairment should use Akchinec-DS Oral Suspension cautiously, potentially requiring dosage modification. Physician consultation is advised. Akchinec-DS Oral Suspension is contraindicated in individuals with severe kidney disease.
LiverCAUTION
Patients with severe hepatic impairment should use Akchinec-DS Oral Suspension cautiously, potentially requiring dose modification. Consult a physician for guidance. Data on Akchinec-DS Oral Suspension use in such patients is limited. Dose alteration is not advised for individuals with mild or moderate liver dysfunction.
What if you forget to take Akchinec-DS Oral Suspension :
Should you forget a dose of Akchinec-DS Oral Suspension, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Akchinec-DS Oral Suspension
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Breathing |



